Product Images Diltiazem Hydrochloride

This is a product description for Diltiazem HCI ER Caps USP 180mg with a LOT number of 8380. It is manufactured by Novast for Ingenus and distributed by Vangard in Scotland, Kentucky. It is a once-a-day dosage and should be stored at 20-25°C. The packaging is trademarked by Omnicare, Inc. It is for institutional use only and the package insert or label should be consulted for dosage information.*

This is a prescription drug package for Diltiazem HCI ER Caps USP containing 240mg. It is manufactured by Novast for Ingenus and packaged by Vangard in Glasgow, KY. The Novast NDC is 50742.250-90 and Ingenus NDC is 0615-8381-39. The LOT number is 8381, and it must be stored at controlled room temperature. The package insert or label should offer dosage information. This package is to be used for institutional purposes only and dispensed in a light-resistant container.*

This text appears to be a report on a clinical trial comparing the effects of Diltiazem hydrochloride extended-release capsules versus a placebo on patients with angina and hypertension. The table displays the percentage of patients who experienced adverse reactions in each group, including headache, dizziness, bradycardia, AV block, edema, and asthenia.*

This is a prescription medication called Diltiazem HCI. It comes in extended-release capsules and each capsule contains either 120mg or 150mg of the active ingredient. The medication is intended for once-a-day dosing. The medication should be stored at room temperature (20°- 25°C or 68°- 77' F) and protected from moisture. It should be dispensed in a light-resistant container. Dosage instructions are available on the package insert or label. The text contains information about different lots and expiration dates of the medication, as well as manufacturing information.*